Rhythm Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $33,251 | $29,078 | $25,967 | $24,234 |
Gross Profit | 29,423 | 25,954 | 22,969 | 21,001 |
EBITDA | -38,358 | -26,788 | -135,912 | -36,990 |
EBIT | -38,743 | -27,179 | -136,317 | -37,407 |
Net Income | -44,970 | -32,261 | -141,372 | -41,633 |
Net Change In Cash | 33,251 | 29,078 | 25,967 | 24,234 |
Free Cash Flow | 14,785 | -29,076 | -80,743 | -29,382 |
Cash | 47,521 | 161,669 | 53,428 | 60,081 |
Basic Shares | 61,219 | 61,011 | 60,143 | 59,211 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $77,428 | $23,638 | $3,154 | $35 |
Gross Profit | 68,126 | 21,505 | 2,555 | -690 |
EBITDA | -168,464 | -174,515 | -168,901 | -135,885 |
EBIT | -170,222 | -175,918 | -170,059 | -136,575 |
Net Income | -184,678 | -183,081 | -68,007 | -130,727 |
Net Change In Cash | 77,428 | 23,638 | 3,154 | 35 |
Cost of Revenue | 68,429 | -41,681 | 38,560 | |
Free Cash Flow | -136,204 | -177,709 | -151,437 | -122,194 |
Cash | 60,081 | 127,677 | 59,248 | 100,854 |
Basic Shares | 57,673 | 52,120 | 49,600 | 44,127 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.73 |
2024-06-30 | -$0.69 |
2024-03-31 | -$2.35 |
2023-12-31 | -$0.70 |
